A linear programming model for allocating HIV prevention funds with state agencies: A pilot study

Health Care Management Science

Volumn 10, Issue 3, 2007, Pages 239-252

  Earnshaw, Stephanie R ^a   Hicks, Katherine ^a   Richter, Anke ^b   Honeycutt, Amanda ^a  

^a RTI HEALTH SOLUTIONS   (United States)

^b NAVAL POSTGRADUATE SCHOOL   (United States)

Author keywords

Economic model; Efficiency; Equity; HIV AIDS; Linear program; Prevention; Resource allocation; State funding decisions

Indexed keywords

ARTICLE; DECISION MAKING; DISEASE TRANSMISSION; ECONOMICS; FEMALE; FINANCIAL MANAGEMENT; GOVERNMENT; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PILOT STUDY; RISK FACTOR; STATISTICAL MODEL; SUBSTANCE ABUSE; SYSTEM ANALYSIS; UNITED STATES;

DECISION MAKING; EFFICIENCY, ORGANIZATIONAL; FEMALE; FINANCING, GOVERNMENT; FLORIDA; GOVERNMENT AGENCIES; HEALTH CARE RATIONING; HEALTH POLICY; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; MODELS, ECONOMIC; PILOT PROJECTS; PROGRAMMING, LINEAR; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 34250829026     PISSN: 13869620     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10729-007-9017-8     Document Type: Article

References (41)

1. Ruiz MS, Gable AR, Kaplan EH, Stoto MA, Fineberg H, Trussell J (2001) No time to lose: getting more from HIV prevention, committee on HIV prevention strategies in the United States, Division of Health Promotion and Disease Prevention. National Academy Press, Washington
2. Academy for Educational Development's Center for Community-based Health Strategies, HIV Prevention Community Planning (2000) Setting HIV prevention priorities: a guide for community planning groups. Academy for Educational Development's Center for Community-based Health Strategies, Washington, DC
3. Brandeau ML (2004) Allocating resources to control infectious diseases. In: Brandeau ML, Sainfort F, Pierskalla WP (eds) Operations research and health care: a handbook of methods and applications. Kluwer, Boston, MA
4. Paltiel AD, Stinnett, AS (1998) Resource allocation and the funding of HIV prevention. In: Holtgrave DR (ed) Handbook of economic evaluation of HIV prevention programs. Plenum, New York
5. Stinnett AA, Paltiel AD (1996) Mathematical programming for the efficient allocation of health care resources, J Health Econ 15:641-653
6. Kaplan EH, Merson MH (2002) Allocating HIV-prevention resources: balancing efficiency and equity. Am J Public Health 92:1905-1907
7. Zaric GS, Brandeau ML (2001) Optimal investment in a portfolio of HIV prevention programs. Med Decis Mak 21:391-408
8. Kaplan EH (1998) Economic evaluation and HIV prevention community planning: a policy analyst's perspective. In: Holtgrave DR (ed) Handbook of economic evaluation of HIV prevention programs. Plenum, New York
9. Pinkerton SD, Abramson PR (1998) The Bernoulli-process model of HIV transmission: applications and implications. In: Holtgrave DR (ed) Handbook of economic evaluation of HIV prevention programs. Plenum, New York
10. Zaric GS, Brandeau ML (2001) Resource allocation for epidemic control over short time horizons, Math Biosci 171:33-58
11. Brandeau ML, Zaric GS, Richter A (2003) Resource allocation for control of infectious diseases in multiple independent populations: beyond cost-effectiveness analysis. J Health Econ 22:575-598
12. Richter A, Loomis B (2005) Health and economic impacts of an HIV intervention in out of treatment substance abusers: evidence from a dynamic model. Health Care Manage Sci 8:67-79
13. Zaric GS, Brandeau ML (2007) A little planning goes a long way: Multi-level allocation of HIV prevention resources, Med Decis Mak 27:71-81
14. Lasry A, Zaric GS, Carter MW (2007) Multi-level resource allocation for HIV prevention: A model for developing countries. Eur J Oper Res 180(2):786-799
15. Tengs TO, Meyer G, Siegel JE, Pliskin JS, Graham JD, Weinstein MC (1996) Oregon's medicaid ranking and cost-effectiveness: is there a relationship? Med Decis Mak 16:99-107
16. Pinkerton SD, Johnson-Masotti AP, Derse A, Layde PM (2002) Ethical issues in cost-effectiveness analysis. Eval Program Plann 25:71-83
17. Holtgrave DR (2004) HIV prevention, cost-utility analysis, and race/ethnicity: methodological considerations and recommendations, Med Decis Mak 24:181-191
18. The Henry J. Kaiser Family Foundation, Cumulative HIV infection cases reported through 2004 among states with confidential namebased reporting. Available at: http://www.statehealthfacts.org/cgi-bin/healthfacts.cgi?action= compare&category=HIV% 2fAIDS&subcategory= Cumulative+Reported+HIV+Infections+%28Cases%29&topic= Cumulative+Reported+HIV+Cases+All+Ages. Accessed November 13, 2006
19. Florida Epidemiologic Profile 2000, HIV/AIDS summary analyses of community planning partnerships, Section 3B, 195-230. Available at: http://www.doh.state.fl.us/disease_ctrl/aids/trends/epiprof/16epiprofgeosum.pdf. Accessed November 13, 2006
20. Kaplan EH, Heimer R (1992) A model-based estimate of HIV infectivity via needle sharing. J Acquir Immune Defic Syndr 5:1116-1118
21. Abdala N, Gleghorn A A, Carney JM, Heimer R (2001) Can HIV-1 contaminated syringes by disinfected? Implications for transmission among IDUs. J Acquir Immune Defic Syndr 28: 487-494
22. Anderson RM, May RM (1998) Epidemiological parameters of HIV transmission. Nature 333:514-519
23. Pinkerton SD, Abramson PR (1997) Effectiveness of condoms in preventing HIV transmission. Soc Sci Med 44:1303-1312
24. Silverman BG, Gross TP (1997) Use and effectiveness of condoms during anal intercourse. Sex Transm Dis 24:11-17
25. Anderson J (2003) Condom use and HIV risk among US adults. Am J Public Health 93:912-914
26. Kahn J (1998) Economic evaluation of primary HIV prevention in injection drug users. In: Holtgrave DR (ed) Handbook of economic evaluation of HIV prevention programs. Plenum, New York
27. Laumann E, Gagnon J, Michael R, Michaels S (1994) The social organization of sexuality: sexual practices in the United States. University of Chicago Press, Chicago, IL
28. Kamb ML, Fishbein M, Douglas JM Jr., Rhodes F, Rogers J, Bolan, G, Zenilman, J, Hoxworth T, Malotte CK, Iatesta M, Kent C, Lentz A, Graziano, S, Byers RH, Peterman TA (1998) Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases. J Am Med Assoc 280:1161-1167
29. Zaric GS, Barnett PG, Brandeau ML (2000) HIV transmission and the cost effectiveness of methadone maintenance. Am J Public Health 90:1100-1111
30. Pinkerton SD, Holtgrave DR, Valdiserri R (1997) Cost-effectiveness of HIV-prevention skills training for men who have sex with men. AIDS 11:347-357
31. Bedimo A, Pinkerton S, Cohen D, Gray B, Farley T (2002) Condom distribution: A cost-utility analysis. Int J STD AIDS 13:384-392
32. Holtgrave DR, Kelly J (1997) Cost-effectiveness of an HIV/AIDS prevention intervention for gay men. AIDS Behav 1:173-180
33. Kahn J, Kegeles S, Hays R, Beltzer N (2001) Cost-effectiveness of the empowerment project, a community-level intervention for young gay men. J Acquir Immune Defic Syndr 27:482-491
34. Holtgrave DR, Reiser WJ, DiFranceisco W (1997) The evaluation of HIV counseling-and-testing services: making the most of limited resources. AIDS Educ Prev 9:105-118
35. Pinkerton SD, Holtgrave DR, DiFranceisco W, Stevenson Y, Kelly, J (1998) Cost-effectiveness of a community-level HIV risk reduction intervention. Am J Public Health 1239-1242
36. Tao G, Remafedi G (1998) Economic evaluation of an HIV prevention intervention for gay and bisexual adolescents. J Acquir Immune Defic Syndr 17:83-90
37. Chesson H, Greenberg J, Hennessy M (2002) The cost-effectiveness of the WINGS intervention: a program to prevent HIV and sexually transmitted diseases among high-risk urban women. BMC Infect Dis 2:24
38. Holtgrave DR, Kelly J (1996) Preventing HIV/AIDS among high-risk urban women: the cost-effectiveness of a behavioral group intervention. Am J Public Health 86:1442-1445
39. Pinkerton SD, Holtgrave DR, Jemmott J III (2000) Economic evaluation of HIV risk reduction intervention in African-American male adolescents. J Acquir Immune Defic Syndr 25:164-172
40. Pinkerton SD, Holtgrave DR, DiFranceisco W, Semann S, Coyle S, Johnson-Masotti A (2000) Cost-threshold analyses of the national AIDS demonstration research HIV prevention interventions. AIDS 14:1257-1268
41. Kahn JG, Washington AE, Showstack JA, Berlin M, Phillips K (1992) Updated estimates of the impact and cost of HIV prevention in injection drug users. Institute for Health Policy Studies, University of California, San Francisco, CA